Ovid Therapeutics Inc OVID:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:36 AM EDT
3.46quote price arrow up+0.01 (+0.23%)
Volume
16,436
52 week range
2.25 - 6.98
Loading...
  • Open3.47
  • Day High3.47
  • Day Low3.42
  • Prev Close3.45
  • 52 Week High6.98
  • 52 Week High Date12/01/20
  • 52 Week Low2.25
  • 52 Week Low Date12/29/20

Key Stats

  • Market Cap234.90M
  • Shares Out67.93M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.75
  • YTD % Change49.35

KEY STATS

  • Open3.47
  • Day High3.47
  • Day Low3.42
  • Prev Close3.45
  • 52 Week High6.98
  • 52 Week High Date12/01/20
  • 52 Week Low2.25
  • 52 Week Low Date12/29/20
  • Market Cap234.90M
  • Shares Out67.93M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.75
  • YTD % Change49.35

RATIOS/PROFITABILITY

  • EPS (TTM)1.68
  • P/E (TTM)2.06
  • Fwd P/E (NTM)-4.56
  • EBITDA (TTM)124.54M
  • ROE (TTM)98.60%
  • Revenue (TTM)221.00M
  • Gross Margin (TTM)-
  • Net Margin (TTM)55.10%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ovid Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company focused on developing medicines for patients and families living with rare neurological disorders. The Company's product pipeline includes two late-stage programs and several early-stage programs. The product candidates in its pipeline includes OV935 (soticlestat), OV329, OV882 and OV815. Soticlestat, which is under late-stage program, is for the treatment of dravet syndrome and lennox-gastaut syndrome. OV329, which...
Jeremy Levin
Chairman
Jeffrey Rona
Chief Financial Officer
Address
1460 Broadway Ste 15044
New York, NY
10036-7329
United States

Top Peers

SYMBOLLASTCHG%CHG
AKBA
Akebia Therapeutics Inc
2.77+0.08+2.97%
PBYI
Puma Biotechnology Inc
5.14-0.09-1.82%
CLVS
Clovis Oncology Inc
4.18+0.06+1.46%
ATNX
Athenex Inc
2.54+0.02+0.60%
RIGL
Rigel Pharmaceuticals Inc
3.27UNCHUNCH